10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, …
Full TXG analysis →
Competitive advantage assessment
Key strengths
Consistent Cash GenerationCash generation is strong and consistent (score 0.88).
Cash Generation ConsistentCash generation is consistent (score 0.88), indicating reliable business model.
The dashed ring is the peer median. Defense scores are percentile ranks
against peers, so 50 is roughly the typical company in this group.
Upgrade to unlock the signals and evidence behind each defense.
Premium access
Unlock full defense analysis
Get key signals, strengths, and risks for every moat dimension.
10x Genomics, Inc. ranks #21 of 68
scored companies in Health Information Services by moat score — the top 31%.
The widest moat in the group is Veeva Systems Inc. (VEEV)
at 88/100.
Moat scores for companies ranked near TXG in Health Information Services
Pricing power is the ability to raise prices without losing volume.
Cost Advantage
Score 59
· 15% of the moat score
A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.
Customer Stickiness
Score 69
· 15% of the moat score
Stickiness is what makes revenue repeat without being re-won every year.
Capital Efficiency
Score 41
· 18% of the moat score
Capital efficiency asks what the company earns on the money tied up in the business.
Resilience
Score 70
· 17% of the moat score
Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.
Scale & Market Position
Score 63
· 15% of the moat score
Scale matters only when it converts into economics.
10x Genomics, Inc. (TXG) scores 57 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #21 of 68 scored companies in Health Information Services, the top 31%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 67 companies in Health Information Services. Its strongest defense is Resilience (70/100) and its weakest is Capital Efficiency (41/100).
How does 10x Genomics, Inc. compare with other Health Information Services companies?
10x Genomics, Inc. ranks #21 of 68 scored companies in Health Information Services by moat score. The widest moat in Health Information Services is Veeva Systems Inc. (VEEV) at 88/100. The companies ranked closest are Premier, Inc. (PINC) at 59 just above it and Omnicell, Inc. (OMCL) at 56 just below it.
How is the moat score calculated?
Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 67 companies in Health Information Services. The defenses are then weighted to produce the overall score out of 100.
Why is 10x Genomics, Inc. scored with the Corporate Default template?
Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.
Which competitive defenses are measured for 10x Genomics, Inc.?
The Corporate Default template measures 6 defenses, and TXG scores: Pricing Power (47), Cost Advantage (59), Customer Stickiness (69), Capital Efficiency (41), Resilience (70), Scale & Market Position (63). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.
We value your privacy
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking 'Accept All', you consent to our use of cookies.
Read our cookie policy
Cookie Preferences
Manage your cookie preferences. Essential cookies are always enabled.